Related Experiment Video
Updated: Aug 27, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
Oscar Cahyadi1, Nadeem Tehami2, Enrique de-Madaria3,4
1St. Josef-Hospital, A Hospital of the Ruhr-University Bochum, 44791 Bochum, Germany.
Post-ERCP pancreatitis (PEP) affects 2-10% of patients, with higher rates in high-risk cases. This review details prevention and management strategies for PEP, a serious complication of endoscopic retrograde cholangiopancreatography.
Area of Science:
- Gastroenterology
- Endoscopy
- Pancreatology
Background:
- Post-ERCP pancreatitis (PEP) is a significant complication of endoscopic retrograde cholangiopancreatography (ERCP).
- PEP incidence ranges from 2-10%, escalating to 30-50% in high-risk patient groups.
- Severe PEP can lead to life-threatening complications like multi-organ failure and mortality.
Purpose of the Study:
- To review the definition, epidemiology, and risk factors associated with PEP.
- To highlight current evidence-based medical and endoscopic strategies for PEP prevention.
- To discuss the latest approaches for managing PEP.
Main Methods:
- Comprehensive literature review of studies on PEP.
- Analysis of risk factors and predictive markers for PEP.
- Evaluation of pharmacological and technical interventions for PEP prevention and management.
Main Results:
- PEP risk is potentially predictable and modifiable.
- Various pharmacological agents and specific endoscopist techniques can influence PEP rates.
- Early identification of high-risk patients is crucial for implementing preventive measures.
Conclusions:
- PEP remains a critical concern following ERCP, necessitating proactive management.
- A combination of risk stratification, pharmacological prophylaxis, and refined endoscopic techniques is essential for reducing PEP incidence and severity.
- Further research into novel prevention strategies is warranted.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis II: Clinical Manifestations and Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

